Literature DB >> 31495063

Protease-activated receptor signaling in intestinal permeability regulation.

Giulia Pontarollo1, Amrit Mann1, Inês Brandão1,2, Frano Malinarich1, Marie Schöpf1, Christoph Reinhardt1,3.   

Abstract

Protease-activated receptors (PARs) are a unique class of G-protein-coupled transmembrane receptors, which revolutionized the perception of proteases from degradative enzymes to context-specific signaling factors. Although PARs are traditionally known to affect several vascular responses, recent investigations have started to pinpoint the functional role of PAR signaling in the gastrointestinal (GI) tract. This organ is exposed to the highest number of proteases, either from the gut lumen or from the mucosa. Luminal proteases include the host's digestive enzymes and the proteases released by the commensal microbiota, while mucosal proteases entail extravascular clotting factors and the enzymes released from resident and infiltrating immune cells. Active proteases and, in case of a disrupted gut barrier, even entire microorganisms are capable to translocate the intestinal epithelium, particularly under inflammatory conditions. Especially PAR-1 and PAR-2, expressed throughout the GI tract, impact gut permeability regulation, a major factor affecting intestinal physiology and metabolic inflammation. In addition, PARs are critically involved in the onset of inflammatory bowel diseases, irritable bowel syndrome, and tumor progression. Due to the number of proteases involved and the multiple cell types affected, selective regulation of intestinal PARs represents an interesting therapeutic strategy. The analysis of tissue/cell-specific knockout animal models will be of crucial importance to unravel the intrinsic complexity of this signaling network. Here, we provide an overview on the implication of PARs in intestinal permeability regulation under physiologic and disease conditions.
© 2019 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.

Entities:  

Keywords:  coagulation; epithelia barrier function; epithelium; gastrointestinal cancer; gut-vascular barrier; inflammatory bowel disease; intestine; microbial proteases; microbiota; protease-activated receptor; tissue factor

Mesh:

Substances:

Year:  2019        PMID: 31495063     DOI: 10.1111/febs.15055

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  8 in total

1.  Expression of Proteinase-Activated Receptor 2 During Colon Volvulus in the Horse.

Authors:  Carlotta Lambertini; Augusta Zannoni; Noemi Romagnoli; Cristiano Bombardi; Maria Morini; Francesco Dondi; Chiara Bernardini; Monica Forni; Riccardo Rinnovati; Alessandro Spadari
Journal:  Front Vet Sci       Date:  2020-11-27

2.  A serine protease secreted from Bacillus subtilis cleaves human plasma transthyretin to generate an amyloidogenic fragment.

Authors:  Daniele Peterle; Giulia Pontarollo; Stefano Spada; Paola Brun; Luana Palazzi; Alexej V Sokolov; Barbara Spolaore; Patrizia Polverino de Laureto; Vadim B Vasilyev; Ignazio Castagliuolo; Vincenzo De Filippis
Journal:  Commun Biol       Date:  2020-12-11

Review 3.  Deciphering the Role of the Coagulation Cascade and Autophagy in Cancer-Related Thrombosis and Metastasis.

Authors:  Charlotte Nicole Hill; Maria Paz Hernández-Cáceres; Catalina Asencio; Begoña Torres; Benjamin Solis; Gareth I Owen
Journal:  Front Oncol       Date:  2020-12-07       Impact factor: 6.244

Review 4.  Oral microbiota in human systematic diseases.

Authors:  Xian Peng; Lei Cheng; Yong You; Chengwei Tang; Biao Ren; Yuqing Li; Xin Xu; Xuedong Zhou
Journal:  Int J Oral Sci       Date:  2022-03-02       Impact factor: 24.897

Review 5.  Pancreatic Proteolytic Enzymes and Cancer: New Support for an Old Theory.

Authors:  Linda L Isaacs
Journal:  Integr Cancer Ther       Date:  2022 Jan-Dec       Impact factor: 3.077

6.  Effects of intermittent hypoxia with thrombin in an in vitro model of human brain endothelial cells and their impact on PAR-1/PAR-3 cleavage.

Authors:  Cindy Zolotoff; Clémentine Puech; Frédéric Roche; Nathalie Perek
Journal:  Sci Rep       Date:  2022-07-19       Impact factor: 4.996

7.  Higher amoebic and metronidazole resistant forms of Blastocystis sp. seen in schizophrenic patients.

Authors:  Freddy Franklin; Arutchelvan Rajamanikam; Chandramathi Samudi Raju; Jesjeet Singh Gill; Benedict Francis; Luke Woon Sy-Cherng; Suresh Kumar
Journal:  Parasit Vectors       Date:  2022-09-05       Impact factor: 4.047

Review 8.  Molecular Mechanisms of Microbiota-Mediated Pathology in Irritable Bowel Syndrome.

Authors:  Yoshiyuki Mishima; Shunji Ishihara
Journal:  Int J Mol Sci       Date:  2020-11-17       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.